Invenomic Capital Management LP Trinity Biotech PLC Transaction History

Invenomic Capital Management LP

  • $1.75 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$1.68 - $3.17 $226,205 - $426,827
-134,646 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$0.88 - $2.55 $234,408 - $679,251
-266,373 Reduced 66.42%
134,646 $293,000
Q1 2020

May 13, 2020
SELL
$0.62 - $1.47 $68,262 - $161,847
-110,100 Reduced 21.54%
401,019 $441,000
Q4 2019

Feb 14, 2020
BUY
$0.69 - $1.2 $352,672 - $613,342
511,119 New
511,119 $526,000

Others Institutions Holding TRIB

# of Institutions
1
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About TRINITY BIOTECH PLC

TRIB Quotes by TradingView
  • Ticker TRIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 38,107,600
  • Market Cap $46.5M
  • Description
  • Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...
More about TRIB
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email